BILIARY TRACT NEOPLASMS
Clinical trials for BILIARY TRACT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT NEOPLASMS trials appear
Sign up with your email to follow new studies for BILIARY TRACT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Global trial seeks to extend lives in Tough-to-Treat bile duct cancer
Disease control OngoingThis large, international study tested whether adding an immunotherapy drug (durvalumab) to standard chemotherapy helps people with advanced bile duct cancer live longer. It involved 810 patients who had not received prior treatment for their advanced disease. The main goal was t…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug duo targets Hard-to-Treat cancers in major trial
Disease control OngoingThis study is testing whether the drugs tucatinib and trastuzumab can help control advanced solid tumors that have specific changes in a protein called HER2. It is for adults with cancers like lung, cervical, or uterine cancer that have spread or cannot be removed by surgery, and…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC